CEBPB and breast carcinoma: p52-C/EBPbeta1 is not observed via immunoblot of breast cancer cell lines with C/EBPbeta antibodies [17], Figure 1a, however breast cancer cell lines exhibit higher molecular weight bands that react with C/EBPbeta antibodies, including C/EBPbeta1-specific antibodies (Figure 1a).